3 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... own benefits and risks ... the hypoglycemia risk ... pharmacotherapy #table
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Roflumilast) Indication ... : Reduce risk of ... Drug Class: Selective ... Dosing: 250 mcg tablet ... to reduce the risk
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... ASA class If ... event, follow ACC algorithm ... Stable patients ... the type of and indication